Dasatinib Tablets
[Dosage form] Tablet
[Indication]
Be indicated for treatment of Leukemia with resistance or intolerance to prior therapy including Imatinib.
[Specification] 20mg, 50mg
[Originator] Sprycel (brand name) from Bristol Myers Squibb